CA
TWST icon

Clearstead Advisors’s Twist Bioscience TWST Stock Holding History

Clearstead Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.87M Sell
37,624
-69,679
-65% -$4.53M 0.04% 277
2026
Q1 		$5.1M Buy
107,303
+99,290
+1,239% +$4.45M 0.05% 233
2025
Q4 		$254K Buy
8,013
+7,986
+29,578% +$249K ﹤0.01% 865
2025
Q3 		$760 Buy
+27
New +$818 ﹤0.01% 2665
2025
Q1 		– Sell
-17
Closed -$790 – 2313
2024
Q4 		$790 Buy
+17
New +$768 ﹤0.01% 1945
2021
Q4 		– Sell
-100
Closed -$11K – 1435
2021
Q3 		$11K Hold
100
– – ﹤0.01% 935
2021
Q2 		$13K Hold
100
– – ﹤0.01% 769
2021
Q1 		$12K Hold
100
– – ﹤0.01% 756
2020
Q4 		$14K Hold
100
– – ﹤0.01% 675
2020
Q3 		$8K Buy
+100
New +$6.23K ﹤0.01% 702

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Clearstead Advisors's TWST Position: Q2 2026 in Review

Clearstead Advisors reduced its Twist Bioscience (TWST) stake by 65% in Q2 2026, selling an estimated $4.53M and leaving 37,624 shares worth $3.87M. The position accounts for 0.04% of the portfolio, ranked #277.

Clearstead Advisors first reported a position in TWST in Q3 2020 and has held it in 10 quarters since. The position peaked at $5.1M in Q1 2026. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Clearstead Advisors held 37,624 shares of Twist Bioscience worth $3.87M as of Q2 2026.
  • Clearstead Advisors sold 69,679 Twist Bioscience shares in Q2 2026, an estimated $4.53M.
  • Twist Bioscience made up 0.04% of Clearstead Advisors's portfolio in Q2 2026, its #277 holding.
  • Clearstead Advisors first reported a position in Twist Bioscience in Q3 2020 and has held it in 10 quarters since.
  • Clearstead Advisors's Twist Bioscience position peaked at $5.1M in Q1 2026.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.